ATE257155T1 - Reagenzien für einen lysergsäurediethylamid- immuntest - Google Patents

Reagenzien für einen lysergsäurediethylamid- immuntest

Info

Publication number
ATE257155T1
ATE257155T1 AT97110644T AT97110644T ATE257155T1 AT E257155 T1 ATE257155 T1 AT E257155T1 AT 97110644 T AT97110644 T AT 97110644T AT 97110644 T AT97110644 T AT 97110644T AT E257155 T1 ATE257155 T1 AT E257155T1
Authority
AT
Austria
Prior art keywords
lysergic acid
reagents
acid diethylamide
immune test
lsd
Prior art date
Application number
AT97110644T
Other languages
English (en)
Inventor
Salvatore Joseph Salamone
Stephen S Vitone
Robert Sundoro Wu
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE257155T1 publication Critical patent/ATE257155T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT97110644T 1996-07-02 1997-06-30 Reagenzien für einen lysergsäurediethylamid- immuntest ATE257155T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2107196P 1996-07-02 1996-07-02

Publications (1)

Publication Number Publication Date
ATE257155T1 true ATE257155T1 (de) 2004-01-15

Family

ID=21802174

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97110644T ATE257155T1 (de) 1996-07-02 1997-06-30 Reagenzien für einen lysergsäurediethylamid- immuntest

Country Status (7)

Country Link
US (2) US6063908A (de)
EP (1) EP0816364B1 (de)
JP (1) JPH1087662A (de)
AT (1) ATE257155T1 (de)
CA (1) CA2209217A1 (de)
DE (1) DE69727009T2 (de)
ES (1) ES2212015T3 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207396B1 (en) 1995-11-20 2001-03-27 Microgenics Corporation Immunoassay reagents and methods for determination of LSD and LSD metabolites
AU2775299A (en) * 1998-02-20 1999-09-06 Microgenics Corporation Immunoassays for determination of lsd and lsd metabolites
US6306616B1 (en) 1998-03-27 2001-10-23 Microgenics Corporation Adsorption type confirmatory assays
EP1066523A2 (de) * 1998-03-27 2001-01-10 Microgenics Corporation Kontrollbestimmungsmethoden für drogen bestehend aus kleinen molekülen
US6548645B1 (en) * 1999-06-18 2003-04-15 Microgenetics Corporation Immunoassay for 2-oxo-3-hydroxy LSD
DE19955582B4 (de) * 1999-11-18 2004-07-22 Jandratek Gmbh Gegenstand mit einer ungeladenen, funktionalisierten Oberfläche umfassend ein Hydrogel, Verfahren zur Herstellung und Verwendung des Gegenstandes sowie Verbindungen zur Herstellung der Oberfläche
US6794496B2 (en) * 2000-04-07 2004-09-21 Roche Diagnostics Corporation Immunoassay for LSD and 2-oxo-3-hydroxy-LSD
US20020072053A1 (en) * 2000-12-08 2002-06-13 Mcnally Alan J. Immunoassay based on DNA replication using labeled primer
DE60239042D1 (de) 2001-12-20 2011-03-10 Randox Lab Ltd Haptene, Immunogene, Antikörper und Konjugate für 2-oxo-3-hydroxy LSD
US8785179B2 (en) * 2002-05-22 2014-07-22 Texas Instruments Incorporated Biosensor and method
US20060223998A1 (en) * 2005-03-30 2006-10-05 Fang-Jie Zhang Synthetic LSD metabolite for preparing haptens used in an LSD metabolite immunoassay
JP6856532B2 (ja) 2015-01-20 2021-04-07 エックスオーシー ファーマシューティカルズ インコーポレイテッドXoc Pharmaceuticals, Inc エルゴリン化合物およびその使用
CA3064274A1 (en) 2017-06-01 2018-12-06 Xoc Pharmaceuticals, Inc. Ergoline derivatives for use in medicine
CN115916173A (zh) * 2020-04-13 2023-04-04 巴塞尔大学医院 Lsd剂量鉴定
EP4329759A4 (de) 2021-04-30 2025-07-16 Mind Medicine Inc Lsd-salzkristallformen
US12611399B2 (en) 2021-05-04 2026-04-28 Definium Therapeutics US, Inc. Movement disorders
US20230064429A1 (en) 2021-08-19 2023-03-02 Mind Medicine, Inc. IMMEDIATE RELEASE FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS
CN114317449B (zh) * 2021-12-28 2023-08-15 无锡迪腾敏生物科技有限公司 麦角乙二胺抗原、麦角乙二胺单克隆抗体、杂交瘤细胞株及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4375414A (en) * 1971-05-20 1983-03-01 Meir Strahilevitz Immunological methods for removing species from the blood circulatory system and devices therefor
US3996345A (en) * 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4199559A (en) * 1974-08-12 1980-04-22 Syva Company Fluorescence quenching with immunological pairs in immunoassays
FR2584720B1 (fr) * 1985-07-11 1987-10-02 Rhone Poulenc Sante Procede de preparation de derives n-methyles de l'ergoline
US5155212A (en) * 1986-05-21 1992-10-13 Abbott Laboratories Phencyclidine and phencyclidine metabolites assay, tracers, immunogens, antibodies and reagent kit
US5144030A (en) * 1987-02-17 1992-09-01 Abbott Laboratories Fluorescene polarization immunoassay for tetrahydrocannabinoids
CH678394A5 (de) * 1990-08-22 1991-09-13 Cerny Erich H
US5237057A (en) * 1992-04-06 1993-08-17 Biosite Diagnostics, Inc. Tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels
FR2725023B1 (fr) * 1994-09-28 1997-01-31 Gks Technologies Diagnostic direct d'haptenes
US5843682A (en) * 1995-11-20 1998-12-01 Boehringer Mannheim Corporation N-1-carboxyalkyl derivatives of LSD

Also Published As

Publication number Publication date
DE69727009T2 (de) 2004-12-09
EP0816364B1 (de) 2004-01-02
US6476199B1 (en) 2002-11-05
US6063908A (en) 2000-05-16
EP0816364A1 (de) 1998-01-07
CA2209217A1 (en) 1998-01-02
JPH1087662A (ja) 1998-04-07
DE69727009D1 (de) 2004-02-05
ES2212015T3 (es) 2004-07-16

Similar Documents

Publication Publication Date Title
DE69727009D1 (de) Reagenzien für einen Lysergsäurediethylamid-Immuntest
US5512493A (en) Method of amplifying the emission signal of a luminescent compound
ES2168092T3 (es) Procedimientos de ensayo que utilizan la luminiscencia inducida.
EP0579676A1 (de) Verfahren für spezifische bindungsassays unter verwendung eines freisetzbaren liganden.
ES2171676T3 (es) Inmunoensayos por quimioluminiscencia para la deteccion de anticuerpos.
EP0411945A3 (en) Heterogeneous immunoassays
DE3883478D1 (de) Peridinin-Chlorophyll-Komplex als fluoreszierende Erkennungszeichen.
DE3580640D1 (de) Testverfahren.
ES2075830T3 (es) Receptores para complejos inmunes, sus metodos de produccion y metodos de ensayo que los utilizan.
KR890701766A (ko) 균질보호분석법
CA2014318A1 (en) Reagents, methods and kits for an amphetamine-class fluorescence polarization immunoassay
DE602004017443D1 (de) Reduktion der migrations-shift-assay-interferenz
KR910020036A (ko) 펜사이클리딘 및 펜사이클리딘 대사체 검정법, 트레이서, 면역원, 항체 및 시약 키트
EP0214847A3 (en) Squarate dye conjugate, process for making it and its use in assay methods and kits
FI891012A0 (fi) Menetelmä ja väline immuunikokeissa esiintyvien häiriötekijöiden kompensoimiseksi
ATE194339T1 (de) Verbesserte immunoessayreagenzien zum nachweis von kannabinoiden
ATE210827T1 (de) Synthetischer standard für immunoassays
CY1106688T1 (el) Αποτιμηση κοβαλαμινης
WO2003106649A3 (en) CONJUGATE TEST AND USES THEREOF
NO943759L (no) Fremgangsmåte for bestemmelse av mengden av en ligand i et biologisk fluid, samt et analysesett for utförelse av en slik fremgangsmåte
AU5752186A (en) Method for measuring free ligands in biological fluids, and assay for measuring same
KR930702683A (ko) 항체 등에 효소 등을 커플링시키기 위한 동종이작용성 제제
AU4440096A (en) Competitive immunoassay using complexed analyte derivatives
DK0994121T3 (da) Forgrenede peptider i analyser for antistoffer
ES2151491T3 (es) Reactivos y procedimientos de cuantificacion de la imipramina o de la desipramina en fluidos biologicos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0816364

Country of ref document: EP

REN Ceased due to non-payment of the annual fee